Central serous chorioretinopathy (CSC) is characterized by neurosensory retinal detachment and vision deterioration at the posterior pole mostly in working-age men. The exact molecular pathogenesis of CSC remains unclear. It is proposed that leakage into subretinal space is caused by increased permeability of choroidal vessels and outer blood-retinal barrier breakdown. The majority of CSC cases are self-limited for a few months with a good visual prognosis. However, if neuroretinal detachment persists longer than 4–6 months, the condition requires treatment because chronic disease induces progressive and irreversible photoreceptor and retinal pigment epithelium (RPE) damage leading to reduced visual acuity. Treatment of CSC aims at achieving a complete resolution of subretinal fluid, and preservation of photoreceptor and RPE. There have been a number of interventions proposed for CSC management. However, treatment of this disease is still a subject of controversy. The purpose of this chapter is to overview pathophysiological hypotheses, diagnosing, and current treatment options for CSC.